These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12815740)
1. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. Carmine A; Buervenich S; Galter D; Jönsson EG; Sedvall GC; Farde L; Gustavsson JP; Bergman H; Chowdari KV; Nimgaonkar VL; Anvret M; Sydow O; Olson L Am J Med Genet B Neuropsychiatr Genet; 2003 Jul; 120B(1):51-7. PubMed ID: 12815740 [TBL] [Abstract][Full Text] [Related]
2. [Association of the polymorphisms in NURR1 gene with Parkinson's disease]. Wu Y; Peng R; Chen W; Zhang J; Li T; Wang Y; Gou Y; Yuan G Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):693-6. PubMed ID: 19065535 [TBL] [Abstract][Full Text] [Related]
3. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445 [TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of Nurr1 haplotypes in Parkinson's disease. Tan EK; Chung H; Zhao Y; Shen H; Chandran VR; Tan C; Teoh ML; Yih Y; Pavanni R; Wong MC Neurosci Lett; 2003 Aug; 347(3):139-42. PubMed ID: 12875905 [TBL] [Abstract][Full Text] [Related]
5. Distribution of haplotypes derived from three common variants of the NR4A2 gene in Japanese patients with schizophrenia. Iwayama-Shigeno Y; Yamada K; Toyota T; Shimizu H; Hattori E; Yoshitsugu K; Fujisawa T; Yoshida Y; Kobayashi T; Toru M; Kurumaji A; Detera-Wadleigh S; Yoshikawa T Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):20-4. PubMed ID: 12627459 [TBL] [Abstract][Full Text] [Related]
6. Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits. Carmine A; Chheda MG; Jönsson EG; Sedvall GC; Farde L; Gustavsson JP; Bergman H; Anvret M; Buervenich S; Olson L Psychiatr Genet; 2003 Mar; 13(1):23-8. PubMed ID: 12605097 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease. Nichols WC; Uniacke SK; Pankratz N; Reed T; Simon DK; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Mov Disord; 2004 Jun; 19(6):649-55. PubMed ID: 15197702 [TBL] [Abstract][Full Text] [Related]
8. Nurr1 mutational screen in Parkinson's disease. Tan EK; Chung H; Chandran VR; Tan C; Shen H; Yew K; Pavanni R; Puvan KA; Wong MC; Teoh ML; Yih Y; Zhao Y Mov Disord; 2004 Dec; 19(12):1503-5. PubMed ID: 15390059 [TBL] [Abstract][Full Text] [Related]
9. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Xu PY; Liang R; Jankovic J; Hunter C; Zeng YX; Ashizawa T; Lai D; Le WD Neurology; 2002 Mar; 58(6):881-4. PubMed ID: 11914402 [TBL] [Abstract][Full Text] [Related]
10. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population. Ruiz-Sánchez E; Yescas P; Rodríguez-Violante M; Martínez-Rodríguez N; Díaz-López JN; Ochoa A; Valdes-Rojas SS; Magos-Rodríguez D; Rojas-Castañeda JC; Cervantes-Arriaga A; Canizales-Quinteros S; Rojas P J Neurol Sci; 2017 Aug; 379():58-63. PubMed ID: 28716280 [TBL] [Abstract][Full Text] [Related]
13. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease. Chen CM; Chen IC; Chang KH; Chen YC; Lyu RK; Liu YT; Hu FJ; Chao CY; Lee-Chen GJ; Wu YR Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):458-62. PubMed ID: 17427185 [TBL] [Abstract][Full Text] [Related]
14. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Hering R; Petrovic S; Mietz EM; Holzmann C; Berg D; Bauer P; Woitalla D; Müller T; Berger K; Krüger R; Riess O Neurology; 2004 Apr; 62(7):1231-2. PubMed ID: 15079038 [No Abstract] [Full Text] [Related]
15. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls. Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder. Smith KM; Bauer L; Fischer M; Barkley R; Navia BA Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):57-63. PubMed ID: 15635701 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population. Shahabi HN; Westberg L; Melke J; Håkansson A; Belin AC; Sydow O; Olson L; Holmberg B; Nissbrandt H J Neural Transm (Vienna); 2009 May; 116(5):567-73. PubMed ID: 19381774 [TBL] [Abstract][Full Text] [Related]
18. Novel polymorphisms of the AP-2 gene (6p24): analysis of association with schizophrenia. Kawanishi Y; Harada S; Tachikawa H; Okubo T; Shiraishi H J Hum Genet; 2000; 45(1):24-30. PubMed ID: 10697959 [TBL] [Abstract][Full Text] [Related]
19. Organization of the human orphan nuclear receptor Nurr1 gene. Torii T; Kawarai T; Nakamura S; Kawakami H Gene; 1999 Apr; 230(2):225-32. PubMed ID: 10216261 [TBL] [Abstract][Full Text] [Related]
20. Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease. Belin AC; Björk BF; Westerlund M; Galter D; Sydow O; Lind C; Pernold K; Rosvall L; Håkansson A; Winblad B; Nissbrandt H; Graff C; Olson L Neurosci Lett; 2007 Jun; 420(3):257-62. PubMed ID: 17537576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]